Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism RIPK1 inhibitors(Receptor-interacting serine/threonine-protein kinase 1 inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
dry age-related macular degeneration | Preclinical | South Korea | 01 Sep 2025 | |
Parkinson Disease | Preclinical | South Korea | 18 Mar 2024 | |
Wet age-related macular degeneration | Preclinical | South Korea | 18 Mar 2024 | |
Alzheimer Disease | Preclinical | South Korea | 09 May 2023 | |
Amyotrophic Lateral Sclerosis | Preclinical | South Korea | 09 May 2023 | |
Multiple Sclerosis | Preclinical | South Korea | 09 May 2023 |